The change in policy at the health system follows the death of a DPD deficient patient and comes during a period of intense competition among Boston hospitals.

GSK has announced that the FDA has accepted its application to review a prefilled syringe version of Shingrix, its shingles vaccine. This new ver ...

Researchers noted that the safety and effectiveness of standard therapies for Merkel cell carcinoma “remains poorly studied.” ...

Vietnam Zoladex Market Key Takeaways: The Vietnam Zoladex market is witnessing notable growth driven by factors such as an increasing prevalence of hormone-related conditions, rising awareness about ...

It’s long been a mystery why folks need a flu vaccine every year, even though immunizations they got in childhood cont ...

Researchers concluded that dabrafenib and trametinib appeared active in the second-line adjuvant setting, “although more follow up is required to confirm.” ...

At 12-year follow-up, C9741 confirmed the sustained long-term benefit of adjuvant dose-dense chemotherapy for node-positive breast cancer. SET2,3 identified patients with ER+ breast cancer who ...

A new blood test can predict how long vaccine immunity will last. The revolutionary breakthrough will help to create more ...

William Werbel, MD, PhD, an assistant professor of medicine at Johns Hopkins and senior study author, said that participants who took Arexvy, which contains an immune-stimulating adjuvant ...